GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment.
Saved in:
| Title: | GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. |
|---|---|
| Authors: | Williams CH; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA., Neitzel LR; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA., Cornell J; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Rea S; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Mills I; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA., Silver MS; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Ahmad JD; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Birukov KG; Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD, USA., Birukova A; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Brem H; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Tyler B; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bar EE; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Hong CC; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA. hongchar@msu.edu.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA. hongchar@msu.edu. |
| Source: | Experimental hematology & oncology [Exp Hematol Oncol] 2024 Jan 31; Vol. 13 (1), pp. 13. Date of Electronic Publication: 2024 Jan 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38291540 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Williams+CH%22">Williams CH</searchLink>; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Neitzel+LR%22">Neitzel LR</searchLink>; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Cornell+J%22">Cornell J</searchLink>; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rea+S%22">Rea S</searchLink>; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mills+I%22">Mills I</searchLink>; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Silver+MS%22">Silver MS</searchLink>; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ahmad+JD%22">Ahmad JD</searchLink>; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Birukov+KG%22">Birukov KG</searchLink>; Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Birukova+A%22">Birukova A</searchLink>; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Brem+H%22">Brem H</searchLink>; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Tyler+B%22">Tyler B</searchLink>; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bar+EE%22">Bar EE</searchLink>; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hong+CC%22">Hong CC</searchLink>; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA. hongchar@msu.edu.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA. hongchar@msu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101590676%22">Experimental hematology & oncology</searchLink> [Exp Hematol Oncol] 2024 Jan 31; Vol. 13 (1), pp. 13. <i>Date of Electronic Publication: </i>2024 Jan 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101590676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2162-3619 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221623619%22">21623619 </searchLink><i>NLM ISO Abbreviation: </i>Exp Hematol Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38291540 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40164-023-00468-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 13 Titles: – TitleFull: GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Williams CH – PersonEntity: Name: NameFull: Neitzel LR – PersonEntity: Name: NameFull: Cornell J – PersonEntity: Name: NameFull: Rea S – PersonEntity: Name: NameFull: Mills I – PersonEntity: Name: NameFull: Silver MS – PersonEntity: Name: NameFull: Ahmad JD – PersonEntity: Name: NameFull: Birukov KG – PersonEntity: Name: NameFull: Birukova A – PersonEntity: Name: NameFull: Brem H – PersonEntity: Name: NameFull: Tyler B – PersonEntity: Name: NameFull: Bar EE – PersonEntity: Name: NameFull: Hong CC IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 01 Text: 2024 Jan 31 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2162-3619 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Experimental hematology & oncology Type: main |
| ResultId | 1 |